Postpneumococcal Moyamoya syndrome case report and review of the postinfective cases

Federica Pinardi1, Andrea Stracciari, Luca Spinardi

  • 1Neurological Unit, S. Orsola-Malpighi University Hospital, Bologna, Italy. federicapinardi@gmail.com

BMJ Case Reports
|February 9, 2013
PubMed

Insights

Pneumococcal meningitis can lead to delayed Moyamoya syndrome (MMS), a rare cerebrovascular disease. This case highlights meningitis as a potential risk factor for developing MMS.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Infectious Disease

Background:

  • Moyamoya syndrome (MMS) is a rare, progressive cerebrovascular disorder characterized by stenosis of the terminal internal carotid arteries and development of collateral vessels.
  • Postinfective vasculopathy, particularly following bacterial meningitis, is an under-recognized cause of MMS.
  • Pneumococcal meningitis is a significant cause of childhood bacterial meningitis and can lead to serious neurological sequelae.

Observation:

  • A 55-year-old man presented with delayed neurological deficits three months after pneumococcal meningitis.
  • Initial symptoms included headache, otalgia, and paresthesiae, followed by acute visual field defects, hemiplegia, hemineglect, and cognitive/behavioral changes.
  • Brain imaging revealed ischemic lesions in the occipital and frontal lobes, with cerebral angiography confirming Moyamoya vessel alterations.

Findings:

  • The patient's presentation and imaging findings were consistent with a delayed manifestation of postpneumococcal Moyamoya syndrome.
  • Cerebral CT and MRI-angiography demonstrated characteristic Moyamoya vessel changes, indicating stenosis and collateral formation.
  • Treatment involved antiplatelets, corticosteroids, and rehabilitation, with no relapses observed at six months follow-up.

Implications:

  • This case underscores meningitis as a potential risk factor for developing Moyamoya syndrome, even with a delayed presentation.
  • Early recognition and management of postinfective vasculopathy are crucial to prevent severe cerebrovascular events.
  • Further research is warranted to elucidate the mechanisms linking meningitis to Moyamoya syndrome and optimize treatment strategies.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.